General Information of the Compound
Compound ID
CP0519910
Compound Name
US9303045, 181
    Show/Hide
Structure
Formula
C21H22N4O3
Molecular Weight
378.432
Canonical SMILES
CN1C2COCC1CC(C2)OC(=O)c1cn(-c2cnccn2)c2ccccc12
    Show/Hide
InChI
InChI=1S/C21H22N4O3/c1-24-14-8-16(9-15(24)13-27-12-14)28-21(26)18-11-25(20-10-22-6-7-23-20)19-5-3-2-4-17(18)19/h2-7,10-11,14-16H,8-9,12-13H2,1H3
    Show/Hide
InChIKey
MLAZAWVPFPIKDR-UHFFFAOYSA-N
Physicochemical Property
logP
2.4389
Rotatable Bonds
3
Heavy Atom Count
28
Polar Areas
69.48
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
7
Complexity
28

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 118436492
ChEMBL ID
CHEMBL3923885
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02227, 5-hydroxytryptamine receptor 3A
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000025 HEK-293T Homo sapiens (Human)  1
1
IC50 = 1.1 nM
   TI
   LI
   LO
   TS